Freshly squeezed

Log In | Sign Up



GE HealthCare

Selected Articles

2025-08-13
GlobeNewswire
Saudi Arabia Teleradiology Market Trends and Company Analysis Report 2025-2033 Featuring FUJIFILM, Koninklijke Philips, General Electric, Oracle, Siemens, GE, McKesson
2025-08-13
Plos.org
Elucidating the functional role of the novel BdP50 protein and extracellular vesicles in the human erythrocyte infection by Babesia divergens
2025-08-13
GlobeNewswire
Global Medical Equipment Repair & Maintenance Market Forecast (2025-2030) by Equipment Type, Service Type, Service Model, End User, Indication, Service Provider and Country
2025-08-13
GlobeNewswire
Hospital Information Systems Company Evaluation Report 2025 | Epic Systems, AdvancedMD, and Dedalus Lead with Integrated EHR, Practice Management, and Digital Transformation Solutions
2025-08-13
GlobeNewswire
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
2025-08-12
GlobeNewswire
Erectile Dysfunction Devices Market Set to Surge at a CAGR of ~8% by 2032 with Rising Global Demand and Technological Advancements | DelveInsight
2025-08-12
GlobeNewswire
Nuclear Molecular Imaging System Outlook Report 2025-2034 | AI and Digital Detectors Revolutionizing the $3+ Billion Market
2025-08-12
Plos.org
Genome-wide identification of modulators of Chlamydia trachomatis parasitophorous vacuole stability highlights an important role for sphingolipid supply
2025-08-12
Biztoc.com
GE HealthCare Technologies Stock: Is Wall Street Bullish or Bearish?
2025-08-12
Barchart.com
GE HealthCare Technologies Stock: Is Wall Street Bullish or Bearish?

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois. US36266G1076 www.gehealthcare.com